Clinical practice guidelines for keratinocyte cancer
From Cancer Guidelines Wiki
Download: Short-form keratinocyte cancer guidelines (recommendations only)
Please also see the following files:
This is a wiki-based guideline. A PDF version of the recommendations in the guideline (short-form guideline), has been made available for download using the link above.
Foreword
Introduction
Summary of recommendations
Plain-language summary
1. Epidemiology
2. Prevention of keratinocyte cancer
3. Early detection
4. Clinical features
- Clinical features of basal cell carcinoma
- Clinical features of cutaneous squamous cell carcinoma and related keratinocyte tumours
5. Pathology
- Pathology of basal cell carcinoma
- Pathology of cutaneous squamous cell carcinoma and related tumours
- Pathology of keratoacanthoma
- Pathology of rare tumours
- Biopsy considerations and the biopsy report
6. Prognosis
7. Surgical treatment
- Considerations before selecting a surgical treatment modality
- Optimal primary excision techniques:
- Post-surgical care and interpretation of the pathology report
- Protocol to manage incompletely resected basal cell carcinoma
- Protocol to manage rapidly growing tumours
- Criteria for choosing Mohs micrographic surgery in preference to other surgical techniques
- Surgical management of advanced cutaneous squamous cell carcinoma
- Surgical treatment – Health system implications and discussion
8. Radiotherapy
- Radiotherapy with or without surgical treatment for keratinocyte cancer
- Radiotherapy for basal cell carcinoma
- Radiotherapy for primary cutaneous squamous cell carcinoma
- Radiotherapy for regional (nodal) metastatic disease (non-distant)
- Radiotherapy for actinic keratosis and cutaneous squamous cell carcinoma in situ
- Radiotherapy for keratoacanthoma
- Recent advances in the radiotherapy of skin cancer
- Management of radiotherapy side effects
- Radiotherapy – Health system implications and discussion
9. Cryotherapy and electrodessication and curettage (EDC)
- Cryotherapy and EDC for basal cell carcinoma
- Cryotherapy and EDC for cutaneous squamous cell carcinoma
- Cryotherapy and EDC – Health system implications and discussion
10. Topical treatments and photodynamic therapy
- Topical treatments (imiquimod, diclofenac, 5-flourouracil, ingenol mebutate)
- Photodynamic therapy
- Topical treatments and photodynamic therapy – Health system implications and discussion
11. Organ transplantation and other conditions associated with immunosuppression
- Epidemiology of keratinocyte cancers in immunosuppressed patients
- Management of keratinocyte cancer risk in organ transplant recipients
- Strategies to manage keratinocyte cancer in organ transplant recipients
- Organ transplantation and other conditions associated with immunosuppression – Health system implications and discussion
12. Metastatic disease and systemic therapies
- Systemic therapies for advanced and metastatic basal cell carcinoma
- Systemic therapies for metastatic cutaneous squamous cell carcinoma
- Metastatic disease and systemic therapies – Health system implications and discussion
13. Follow-up after treatment for keratinocyte cancer
14. The role of primary care in the prevention and management of keratinocyte cancer
15. Economics of keratinocyte cancer
16. Common concerns raised by patients
Appendices
- TNM classification of primary cutaneous carcinomas
- Guideline development process
- List of clinical questions
- Technical report
- Working party members and contributors
- Declarations of interest register
- Glossary of technical terms and abbreviations